Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazumi Kondo
Observed names:
K Kondo,
K. KONDO,
K. Kondo,
KAZUMI KONDO,
Kazumi KONDO
Institution:
Otsuka (Japan)
Observed institutions:
Otsuka (Japan),
Okayama University,
Institute of Medicinal Molecular Design
OpenAlex ID:
A5109425960
OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats
1998
·
Yoshitaka Yamamura
, Shigeki Nakamura
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
367
OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist
1991
·
Yoshitaka Yamamura
, Hidenori Ogawa
, et al.
·
Science
·
278
7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist
1999
·
Kazumi Kondo
, Hidenori Ogawa
, et al.
·
Bioorganic & Medicinal Chemistry
·
139
Orally Active, Nonpeptide Vasopressin V2 Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and Related Compounds
1996
·
Hidenori Ogawa
, Hiroshi Yamashita
, et al.
·
Journal of Medicinal Chemistry
·
100
Novel Design of Nonpeptide AVP V2Receptor Agonists: Structural Requirements for an Agonist Having 1-(4-Aminobenzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepine as a Template
2000
·
Kazumi Kondo
, Hidenori Ogawa
, et al.
·
Journal of Medicinal Chemistry
·
67
A facile procedure for oxidative cleavage of enolic olefins to the carbonyl compounds with ruthenium tetroxide (RuO4)
1985
·
Sigeru Torii
, Tsutomu Inokuchi
, et al.
·
The Journal of Organic Chemistry
·
59
Phosphorylation of Cytohesin-1 by Fyn Is Required for Initiation of Myelination and the Extent of Myelination During Development
2012
·
Junji Yamauchi
, Yuki Miyamoto
, et al.
·
Science Signaling
·
55
Characterization of Orally Active Nonpeptide Vasopressin V2 Receptor Agonist. Synthesis and Biological Evaluation of Both the (5R)- and (5S)-Enantioisomers of 2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin- 5-yl]-N-isopropylacetamide
2002
·
Kazumi Kondo
, Keizo Kan
, et al.
·
Journal of Medicinal Chemistry
·
55
Structural analysis of human glutamine:fructose‐6‐phosphate amidotransferase, a key regulator in type 2 diabetes
2008
·
Yuichiro Nakaishi
, Masahiko Bando
, et al.
·
FEBS Letters
·
47
PDF
Characterization of a novel nonpeptide vasopressin V2‐agonist, OPC‐51803, in cells transfected human vasopressin receptor subtypes
2000
·
Shigeki Nakamura
, Yoshitaka Yamamura
, et al.
·
British Journal of Pharmacology
·
37
PDF
Three-Dimensional Structure Database of Natural Metabolites (3DMET): A Novel Database of Curated 3D Structures
2013
·
Miki H. Maeda
, Kazumi Kondo
·
Journal of Chemical Information and Modeling
·
30
Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihydro-2(1H)-quinolinones
1993
·
Hidenori Ogawa
, Yoshitaka Yamamura
, et al.
·
Journal of Medicinal Chemistry
·
30
Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor
2022
·
Emiliano Tamanini
, Shin Miyamura
, et al.
·
ACS Medicinal Chemistry Letters
·
27
Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
2000
·
Shigeki Nakamura
, Takahiro Hirano
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
25
Synthesis of (3R,4R)-3-(benzyloxy)-4-(formyloxy)-1-nitro-1-cyclopentene, a chiral synthon for prostaglandin syntheses, from D-glucose
1986
·
Sigeru Torii
, Tsutomu Inokuchi
, et al.
·
The Journal of Organic Chemistry
·
24
Electrogenerated Acid as an Efficient Catalyst for the Protection and Deprotection of Alcohols with Dihydropyran and Transesterification of Glyceride
1985
·
Sigeru Torii
, Tsutomu Inokuchi
, et al.
·
Bulletin of the Chemical Society of Japan
·
24
An amino acid residue whose change by mutation affects drug binding to the HERG channel
2001
·
Kuniaki Ishii
, Kazumi Kondo
, et al.
·
FEBS Letters
·
23
PDF
Novel Tetrafunctional Probes Identify Target Receptors and Binding Sites of Small-Molecule Drugs from Living Systems
2020
·
Rin Miyajima
, Koji Sakai
, et al.
·
ACS Chemical Biology
·
17
Influence of acute elevation of plasma AVP level on rat vasopressin V2 receptor and aquaporin-2 mRNA expression
1998
·
Y Terashima
, K Kondo
, et al.
·
Journal of Molecular Endocrinology
·
15
PDF
Studies on positive inotropic agents. V. Synthesis of 1-heteroaroylpiperazine derivatives.
1988
·
HIDENORI OGAWA
, SHIGEHARU TAMADA
, et al.
·
Chemical and Pharmaceutical Bulletin
·
13
PDF
The Ylid Route to Fluorodienes
1984
·
Kazumi Kondo
, Sylvain Cottens
, et al.
·
Chemistry Letters
·
11
Practical stereoselective synthesis of (2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl)acetic acid
2000
·
Tomoichi Shinohara
, Kazumi Kondo
, et al.
·
Chirality
·
9
Effects of OPC-51803, a Novel, Nonpeptide Vasopressin V2-Receptor Agonist, on Micturition Frequency in Brattleboro and Aged Rats
2003
·
Shigeki Nakamura
, Takahiro Hirano
, et al.
·
Journal of Pharmacological Sciences
·
8
PDF
Antidiuretic Effects of a Novel Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Dogs
2004
·
Shigeki Nakamura
, Takahiro Hirano
, et al.
·
Journal of Pharmacological Sciences
·
7
PDF
Recent discovery and development of non-peptide vasopressin V2receptor agonists
2002
·
Kazumi Kondo
·
Expert Opinion on Therapeutic Patents
·
6
Show more works
View as search
Works count:
41
Citation count:
1,497
H-index:
17
I10-index:
21
Year
Topic
Type